739 related articles for article (PubMed ID: 18786708)
1. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
Montel SR; Bungener C
Surg Neurol; 2009 Aug; 72(2):105-10; discussion 110-1. PubMed ID: 18786708
[TBL] [Abstract][Full Text] [Related]
2. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
Montel SR; Bungener C
Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
[TBL] [Abstract][Full Text] [Related]
3. What relation is there between deep brain stimulation and coping strategies in Parkinson's disease?
Montel S; Bungener C
Mov Disord; 2008 Sep; 23(12):1780-4. PubMed ID: 18661551
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson's disease.
Montel S; Bonnet AM; Bungener C
J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):95-102. PubMed ID: 19150974
[TBL] [Abstract][Full Text] [Related]
5. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
[TBL] [Abstract][Full Text] [Related]
6. Depression and coping as predictors of change after deep brain stimulation in Parkinson's disease.
Soulas T; Sultan S; Gurruchaga JM; Palfi S; Fénelon G
World Neurosurg; 2011; 75(3-4):525-32. PubMed ID: 21600507
[TBL] [Abstract][Full Text] [Related]
7. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
8. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
9. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial.
Schüpbach WM; Maltête D; Houeto JL; du Montcel ST; Mallet L; Welter ML; Gargiulo M; Béhar C; Bonnet AM; Czernecki V; Pidoux B; Navarro S; Dormont D; Cornu P; Agid Y
Neurology; 2007 Jan; 68(4):267-71. PubMed ID: 17151341
[TBL] [Abstract][Full Text] [Related]
10. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
11. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
12. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
14. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
[TBL] [Abstract][Full Text] [Related]
15. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.
Siderowf A; Jaggi JL; Xie SX; Loveland-Jones C; Leng L; Hurtig H; Colcher A; Stern M; Chou KL; Liang G; Maccarone H; Simuni T; Baltuch G
Mov Disord; 2006 Jun; 21(6):746-53. PubMed ID: 16463342
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial morbidity of Graves' orbitopathy.
Kahaly GJ; Petrak F; Hardt J; Pitz S; Egle UT
Clin Endocrinol (Oxf); 2005 Oct; 63(4):395-402. PubMed ID: 16181231
[TBL] [Abstract][Full Text] [Related]
18. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
20. Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience.
Kishore A; Rao R; Krishnan S; Panikar D; Sarma G; Sivasanakaran MP; Sarma S
Mov Disord; 2010 Oct; 25(14):2438-44. PubMed ID: 20976738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
